Page last updated: 2024-08-17

adenosine diphosphate and isorhapontigenin

adenosine diphosphate has been researched along with isorhapontigenin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albadawi, DAI; Chaggar, V; Dash, PR; Patel, K; Patra, PH; Ravishankar, D; Salamah, M; Vaiyapuri, R; Vaiyapuri, S; Watson, KA; Williams, HF	1

Other Studies

1 other study(ies) available for adenosine diphosphate and isorhapontigenin

Article	Year
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation. European journal of pharmacology, 2019, Nov-05, Volume: 862 Topics: Adenosine Diphosphate; Animals; Blood Platelets; Drug Evaluation, Preclinical; Female; Healthy Volunteers; Humans; Inhibitory Concentration 50; Male; Mice; Models, Animal; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y12; Resveratrol; Signal Transduction; Stilbenes; Thrombosis	2019

Article

Year

Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.

European journal of pharmacology, 2019, Nov-05, Volume: 862

Topics: Adenosine Diphosphate; Animals; Blood Platelets; Drug Evaluation, Preclinical; Female; Healthy Volunteers; Humans; Inhibitory Concentration 50; Male; Mice; Models, Animal; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y12; Resveratrol; Signal Transduction; Stilbenes; Thrombosis

2019